Belarus to Stop Inflation by Simply Banning Consumer Price Increases

-
Alexander Lukashenko banned consumer price rises in Belarus citing “exorbitant” inflation, according to state media reports. The move comes after an “outrageous” surge in...

Weed Stocks Soar on Biden Pardon, Promised Review

-
Most cannabiselated stocks posted double-digit gains Thursday, with all the gains coming after President Joe Biden announced a blanket pardon for people who had...

AMD Warns of 15% Profit Shortfall, Drags Chipmaker Stocks Lower

-
After markets closed Thursday, Advanced Micro Devices Inc. (NASDAQ: AMD) released preliminary third-quarter results that fell far short of prior guidance and send the...

7 ‘Strong Buy’ Dividend Kings to Grab Now in Case We...

-
At 24/7 Wall St., we know how important dividend size, stability and growth are to growth and income investors who need a dependable stream...

Congress Committee Asks the DoJ for Legal Assessment of CBDCs in...

-
Members of the United States House of Representatives Committee on Financial Services sent a letter to the DoJ earlier today asking for a legal...

Crypto Payment Apps Market Size Expected to Reach $2.15B by 2030:...

-
The global crypto payment app market cap is expected to hit $2.15 billion from 2022 to 2030 at a compound annual growth rate (CAGR)...

Here’s How You Can Easily Track The Idaho Tax Rebate Online

-
Lawmakers in Idaho approved a new tax rebate last month and have laready started processing the payments. The state expects to send all the...

Investors Can Soon Short Jim Cramer with Tuttle Capital’s Inverse Cramer...

-
Tuttle Capital Management has filed two new exchange-traded funds (ETFs) based on the stock picks of television personality Jim Cramer. Called Inverse Cramer ETF...

Transit Swap Hacker Offers to Return 90% of Funds if Users...

-
A hacker behind the recent Transit Swap exploit hinted at returning additional funds after the first stage of user refunds is completed, according to...

UBS Analyst Gets Immunovant Prediction Horribly Wrong After Stock Price Doubles...

-
Shares of autoimmune disease focused biopharma company Immunovant Inc (US:IMVT) mounted an impressive sharp gain of 107% since the beginning of last week as...